The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever

Abstract

Our data, though limited to only one patient, emphasize that therapeutic intervention with canakinumab seems to be improve kidney function in colchicine-resistant FMF with renal amyloidosis.